149 related articles for article (PubMed ID: 14599986)
1. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus.
Liu XF; Zou SQ; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):285-9. PubMed ID: 14599986
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus].
Liu X; Zou S; Qiu F
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):420-2. PubMed ID: 12139797
[TBL] [Abstract][Full Text] [Related]
3. [The retrospective analysis of HBV and HCV infection in cholangiocarcinoma].
Zou SQ; Liu XF; Guo RX; Li CL; Zhou XS; Zhu XG; Huang ZQ
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):417-9. PubMed ID: 12895347
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients.
Lu H; Ye MQ; Thung SN; Dash S; Gerber MA
Chin Med J (Engl); 2000 Dec; 113(12):1138-41. PubMed ID: 11776153
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
Qu Z; Cui N; Qin M; Wu X
Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
10. [Expression of five different antigens of HBV in human intrahepatic cholangiocarcinoma and cholangiohepatocarcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):252-5. PubMed ID: 8174460
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese population.
Wu Y; Wang T; Ye S; Zhao R; Bai X; Wu Y; Abe K; Jin X
Hum Pathol; 2012 Jan; 43(1):56-61. PubMed ID: 21777950
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological comparison between intrahepatic cholangiocarcinoma arising in livers positive and negative for hepatitis B or C virus.
Wakabayashi H; Hashimoto N; Okano K; Inoue T; Kakinoki K; Izuishi K; Suzuki Y
Liver Int; 2008 May; 28(5):717-8. PubMed ID: 18433399
[No Abstract] [Full Text] [Related]
13. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction.
Yin F; Chen B
Chin Med J (Engl); 1998 Dec; 111(12):1068-70. PubMed ID: 11263365
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of hepatitis B virus genes in human primary intrahepatic cholangiocarcinoma and its surrounding tissue].
Wang W; Gu G; Hu M
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):127-30. PubMed ID: 9206046
[TBL] [Abstract][Full Text] [Related]
15. [Case-control study of risk factors in cholangiocarcinoma].
Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
Chen RF; Li ZH; Zou SQ; Chen JS
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
[TBL] [Abstract][Full Text] [Related]
17. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear factor kappa B in hepatitis C virus core gene transfected cholangiocarcinoma cells.
Liu X; Zou S; Qiu F
Chin Med J (Engl); 2002 Jul; 115(7):998-1001. PubMed ID: 12150729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
